Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Laderoute

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of the National Cancer Institute|February 21, 1996
Re: Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancersM P Laderoute
Immunology Today|July 1, 1990
Further speculations on the mutant AT alleleM P Laderoute
Anticancer Research|September 1, 1996
Alterations in p53 do not correlate with radioresistant DNA synthesisM P Laderoute
Journal of the National Cancer Institute|September 4, 1996
Modernized version of Todaro and De Larco's 1978 hypothesis on the autocrine nature of tumor growthM P Laderoute
British Journal of Cancer|January 8, 2004
Improved safety and effectiveness of imaging predicted for MR mammographyM P Laderoute
Lancet (London, England)|July 17, 1999
Debate on Di Bella therapyM P Laderoute
Molecular Carcinogenesis|July 1, 1994
A new perspective on the nature of the cancer problem: anti-cellular senescenceM P Laderoute
Anticancer Research|November 1, 1994
The inhibition of apoptosis by alpha-fetoprotein (AFP) and the role of AFP receptors in anti-cellular senescenceM P Laderoute, L M Pilarski
Scandinavian Journal of Immunology|March 1, 1995
Apoptosis among CD45RA-/low CD3+ progeny accompanies differentiation of human multinegative thymocytesL M Pilarski, M P Laderoute, D Rutkowski
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Monoclonal antibodies directed against a widespread oncofetal antigen: the alpha-fetoprotein receptorR Moro, T Tamaoki, T G Wegmann, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of the National Cancer Institute|February 21, 1996
Re: Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancersM P Laderoute
Immunology Today|July 1, 1990
Further speculations on the mutant AT alleleM P Laderoute
Anticancer Research|September 1, 1996
Alterations in p53 do not correlate with radioresistant DNA synthesisM P Laderoute
Journal of the National Cancer Institute|September 4, 1996
Modernized version of Todaro and De Larco's 1978 hypothesis on the autocrine nature of tumor growthM P Laderoute
British Journal of Cancer|January 8, 2004
Improved safety and effectiveness of imaging predicted for MR mammographyM P Laderoute
Lancet (London, England)|July 17, 1999
Debate on Di Bella therapyM P Laderoute
Molecular Carcinogenesis|July 1, 1994
A new perspective on the nature of the cancer problem: anti-cellular senescenceM P Laderoute
Anticancer Research|November 1, 1994
The inhibition of apoptosis by alpha-fetoprotein (AFP) and the role of AFP receptors in anti-cellular senescenceM P Laderoute, L M Pilarski
Scandinavian Journal of Immunology|March 1, 1995
Apoptosis among CD45RA-/low CD3+ progeny accompanies differentiation of human multinegative thymocytesL M Pilarski, M P Laderoute, D Rutkowski
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1993
Monoclonal antibodies directed against a widespread oncofetal antigen: the alpha-fetoprotein receptorR Moro, T Tamaoki, T G Wegmann, et al.
Pageof 2